JPJean-Pierre Pujol

Jean-Pierre Pujol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jean-Pierre Pujol has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Matrix Gene Expression in Dermal Fibroblasts Cultured on Hyaluronan-coated Polysulfone Membranes

    by J. Attia, K. Boumédiène, J.P. Pujol, J.M. Valleton, E. Huet, Q.T. Nguyen

    Polysulfone (PSU) membranes, coated and uncoated hyaluronan (HA), were compared for their ability to allow dermal fibroblast express genes related to extracellular matrix synthesis and remodeling. Fibroblasts type I and type III collagens were studied on both types of membranes; only type I collagen was synthesized on control cultures in plastic Petri dishes, whereas type III collagen was also expressed on PSU membranes. Expression of metalloproteinase (MMP)1, MMP3, and MMP2 was enhanced on PSU and HA-coated PSU membranes, with a lower level of MMP2 on HA-covered membranes. These membranes promote fetal-like matrices that provide good support for skin wound healing as well as favor nonscarring tissue repair.


  • Open Access

    For intra-articular delivery of chondroitin sulfate

    by M David-Raoudi, R Mendichi, J P Pujol


  • Rhein, the metabolite of diacerhein, reduces the proliferation of osteoarthritic chondrocytes and synoviocytes without inducing apoptosis

    by F. Legendre, A. Heuze, K. Boukerrouche, S. Leclercq, K. Boumediene, P. Galera, F. Domagala, J. ‐P. Pujol, H. Ficheux

    Objective: The aim of this study was to determine the effects of pharmacologically relevant concentrations of rhein (1,8‐dihydroxy‐3‐carboxyanthraquinone) on the cell proliferation rate of human chondrocytes and synoviocytes. Methods: Cultures of human osteoarthritic synoviocytes and chondrocytes were incubated with 10−6, 10−5, and 10−4 M rhein. [3H]thymidine incorporation was used to determine rhein proliferative effects after incubation periods of 24 h, 48 h, and 1 week. The cytotoxicity of the drug was assayed with a nonradioactive assay kit. Nuclear extracts were used to detect variations in cell‐cycle proteins (p21, p27, and cyclin D1) by Western blotting. The effect of rhein on apoptosis was investigated by measurement of caspase‐3/7 activity and DNA fragmentation. Results: Rhein was found to downregulate the proliferation rate of both chondrocytes and synoviocytes, two‐fold for 10−5 M rhein and five‐ to six‐fold for 10−4 M rhein. No cytotoxicity of the drug was observed. Rhein (10−4 M) decreased caspase‐3/7 activity and did not induce DNA fragmentation. Western blots showed that 10−4 M rhein increased the expression of p21 and/or p27, but not that of cyclin D1. Conclusions: Rhein has previously been shown to reduce the interleukin (IL)‐1β deleterious effects on osteoarthritis (OA) cartilage through inhibition of the expression of degrading enzymes. Here, rhein was also found to inhibit proliferation of both synoviocytes and chondrocytes, suggesting that the drug may decrease the development of the inflammatory synovial tissue that accompanies joint pathologies. Both its anti‐catabolic and anti‐proliferative effects may explain its beneficial effect in the treatment of joint diseases.


  • Differential effects of hyaluronan and its fragments on fibroblasts: Relation to wound healing

    by Maha David‐Raoudi, Frédéric Tranchepain, Brigitte Deschrevel, Jean‐Claude Vincent, Patrick Bogdanowicz, Karim Boumediene, Jean‐Pierre Pujol

    Hyaluronan (HA) is involved in wound healing and its biological properties depend on its molecular size. The effects of native HA and HA‐12 and HA‐880 saccharide fragments on human fibroblast proliferation and expression of matrix‐related genes were studied. The three HA forms promoted cell adhesion and proliferation. Matrix metalloproteinase‐1 and ‐3 mRNA were increased by all HA forms, whereas only HA‐12 stimulated the expression of the tissue inhibitor of metalloproteinase 1. HA‐12 enhanced type I collagen and transforming growth factor‐β (TGF‐β) 1 expression. Interestingly, HA‐12 and native HA stimulated type III collagen and TGF‐β3. HA and its fragments activated Akt and extracellular‐regulated kinases 1/2 and p38. Inhibition of these signaling pathways suggested their implication in most of the effects. Only native HA activated nuclear factor‐κB and activating protein 1. Use of CD44 siRNA suggests that this HA receptor is partly implicated in the effects, although it does not rule out the involvement of other receptors. Depending on its size, HA may exert differential regulation on the wound‐healing process. Furthermore, the HA up‐regulation of type III collagen and TGF‐β3 expression suggests that it may promote a fetal‐like cell environment that favors scarless healing.


  • Interleukin-1 and Transforming Growth Factor-ß 1 as Crucial Factors in Osteoarthritic Cartilage Metabolism

    by Jean-Pierre Pujol, Christos Chadjichristos, Florence Legendre, Catherine Baugé, Gallic Beauchef, Rina Andriamanalijaona, Philippe Galéra, Karim Boumediene

    In osteoarthritis (OA), interleukin-1 (IL-1) stimulates the expression of metalloproteinases and aggrecanases, which induce cartilage degradation. IL-1 is also capable of reducing the production of cartilage-specific macromolecules, including type II collagen, through modulation of the transcription factors Sp1 and Sp3. Conversely, Transforming growth factor-ß (TGF-β) counteracts with most of the IL-1 deleterious effects and contributes to cartilage homeostasis. However, OA chondrocytes progressively loose the expression of TGF-β type II receptor and become insensitive to the factor. This downregulation is also driven by IL-1. This review provides insights into the molecular mechanisms that underly the interplay between IL-1 and TGF-β in OA cartilage metabolism and enlightens the central role of Sp1 and Sp3 transcription factors in the matrix pathological alterations.


    • 25 September 2007
      • Vol. 25  (4) , 546-55

    Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways.

    by F Legendre, P Bogdanowicz, G Martin, F Domagala, S Leclercq, J-P Pujol, H Ficheux

    To determine the effects of rhein on the expression of matrix metalloproteinases (MMP-1, -3, 13) and ADAMTs 4, 5 (a disintegrin and metalloproteinase with thrombospondin type-I repeat)/aggrecanases-1, -2 in interleukin-1-stimulated bovine articular chondrocytes, and to investigate the signalling pathways involved in the effects of the drug on gene expression and cell proliferation. Bovine chondrocytes were treated with 10(-4) M rhein for 18 h, followed by 10 ng/ml IL-1Beta for 30 min (cytoplasmic extracts) or 24 h (RNA extraction and EMSA). mRNA was assessed by RT-PCR for the expression of MMPs and aggrecanases, and the phosphorylation of MAP kinases was studied by Western blotting. NF-kappaB and AP-1 DNA binding were determined by gel retardation assay. The effects of inhibitors of these signalling pathways were compared to those of rhein. The proliferation of human chondrocytes and synoviocytes treated with the drug was also investigated. IL-1Beta-induced stimulation of the MMPs and aggrecanase-1 was markedly inhibited by rhein. The drug reduced IL-1Beta-induced NF-kappaB and AP-1 DNA binding, as well as the phosphorylation of ERK and JNK. Similar effects were produced by the specific inhibitors of these signalling pathways. In addition, rhein reduced the proliferation of both human chondrocytes and synoviocytes. Our data indicate that rhein may reduce the deleterious effects of IL-1Beta on osteoarthritic cartilage through its effects on the ERK- and JNK-dependent pathways. Both its anti-catabolic and anti-proliferative properties may explain its value in the treatment of joint diseases.


    • 1 January 2004
      • Vol. 41, 549-61

    Articular chondrocytes cultured in hypoxia: their response to interleukin-1beta and rhein, the active metabolite of diacerhein.

    by G Martin, P Bogdanowicz, F Domagala, H Ficheux, J-P Pujol

    In the present report, we show that bovine articular chondrocytes cultured in low oxygen tension, i.e. in conditions mimicking their hypoxic in vivo environment, respond to IL-1beta (10 ng/ml) by an increased DNA binding activity of NF-kappaB and AP-1 transcription factors. Incubation of the cells with 10(-5) M rhein for 24 h was found to reduce this activity, particularly in the case of AP-1. Mitogen activated kinases (ERK-1 and ERK-2) were activated by exposure of the chondrocytes to 1-h treatment with IL-1beta. This effect was greater in hypoxia (3% O(2)) than in normoxia (21% O(2)). Rhein was capable of reducing the IL-1beta-stimulated ERK1/ERK2 pathway whatever the tension of oxygen present in the environment. The mRNA steady-state levels of collagen type II (COL2A1) and aggrecan core protein were found to be significantly increased by a 24-h treatment with 10(-5) M rhein. This stimulating effect was also observed in the presence of IL-1beta, suggesting that the drug could prevent or reduce the IL-1beta-induced inhibition of extracellular matrix synthesis. IL-1-induced collagenase (MMP1) expression was significantly decreased by rhein in the same conditions. In conclusion, rhein can effectively inhibit the IL-1-activated MAPK pathway and the binding of NF-kappaB and AP-1 transcription factors, two key factors involved in the expression of several pro-inflammatory genes by chondrocytes. In addition, the drug can reduce the procatabolic effect of the cytokine, by reducing the MMP1 synthesis, and enhance the synthesis of matrix components, such as type II collagen and aggrecan. These results may explain the anti-osteoarthritic properties of rhein and its disease-modifying effects on OA cartilage, in spite of absence of inhibition at prostaglandin level.


    • 1 December 1996
      • Vol. 46, S8-10

    [Physiopathology of arthrotic cartilage].

    by J P Pujol, P Galéra, D Vivien, F Redini, K Boumediene